ACURX PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.17 USD | +2.36% |
|
+4.83% | -43.34% |
| 05-02 | Acurx Pharmaceuticals, Inc. Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global Scientific Conference | CI |
| 04-04 | Top Premarket Gainers | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-04-30 | 2024-05-01 | 2024-05-02 | 2024-05-03 | |
|---|---|---|---|---|
| Last | 2.2 $ | 2.16 $ | 2.12 $ | 2.17 $ |
| Volume | 36 147 | 78 610 | 25 535 | 32 860 |
| Change | +0.46% | -1.82% | -1.85% | +2.36% |
| Opening | 2.13 | 2.21 | 2.15 | 2.20 |
| High | 2.33 | 2.32 | 2.22 | 2.21 |
| Low | 2.10 | 2.13 | 2.06 | 2.10 |
Performance
| 1 day | +2.36% | ||
| 1 week | +4.83% | ||
| Current month | -1.36% | ||
| 1 month | +10.71% | ||
| 3 months | -31.97% | ||
| 6 months | -33.84% | ||
| Current year | -43.34% | ||
| 1 year | -25.94% |
Volumes
marketsDaily volume
32 860
Estimated daily volume
32 860
Avg. Volume 20 sessions
87 267
Daily volume ratio
0.38
Avg. Volume 20 sessions USD
189 369.39
Record volume 1
14 615 530
Record volume 2
9 683 739
Record volume 3
8 200 608
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
34 336 131
Net sales (USD)
0
Number of employees
4
Sales / Employee (USD)
0
Free-Float
84.8 %
Free-Float capitalization (USD)
29 118 099
Average Daily Capital Traded
0.55%
Highs and lows
1 week
2.02
2.33
1 month
1.522.33
Current year
1.525.28
1 year
1.178.82
3 years
1.178.82
5 years
1.178.82
10 years
1.178.82
Indicators
Moving average 5 days
2.17
Moving average 20 days
1.97
Moving average 50 days
2.35
Moving average 100 days
2.99
Price spread / (MMA5)
-0.09%
Price spread / (MMA20)
-9.41%
Price spread / (MMA50)
+8.46%
Price spread / (MMA100)
+37.67%
STIM
RSI 9 days
54.83
RSI 14 days
49.86
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +2.36% | +4.83% | -43.34% | -25.94% | 34.34M | ||
| -0.47% | +15.77% | +25.69% | -6.95% | 47.9B | ||
| +1.09% | -1.55% | +46.90% | -10.54% | 41.42B | ||
| +0.55% | -4.90% | -3.46% | +21.13% | 40.7B | ||
| +0.80% | +7.02% | -6.20% | +15.95% | 28.92B | ||
| +2.64% | +0.23% | +9.17% | +68.75% | 25.55B | ||
| +1.34% | +6.29% | -20.42% | -25.83% | 19.27B | ||
| +2.24% | +20.65% | +0.17% | -8.02% | 12.15B | ||
| +0.38% | -0.85% | +28.07% | +91.32% | 12.14B | ||
| +1.56% | +1.94% | -1.24% | +23.22% | 11.99B | ||
| +1.65% | +12.21% | +19.33% | +21.64% | 11.64B | ||
| +0.70% | +3.19% | -4.01% | -9.45% | 9.53B | ||
| +2.58% | +11.79% | +40.17% | +65.91% | 6.85B | ||
| +0.18% | +15.26% | +16.21% | +83.51% | 6.71B | ||
| +1.64% | -0.92% | +23.62% | -19.41% | 6.66B | ||
| -0.94% | +2.44% | +7.53% | -33.84% | 6.6B | ||
| Average | +1.14% | +6.47% | +8.64% | +15.72% | ||
| Weighted average by Cap. | +0.91% | +5.27% | +13.19% | +13.61% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
adcc883c000c10f3a9c44b.VdtYoa1hxh2WFrDQfyhb9OnCfnxbZ8DAKGFznQ4VCyY.DZ43zJ1YhHjzIsO4D24Ok7CdFjcCJa2NGDM8qWwtXGAP6CqT-Uz0LPBOiA
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 15:59:52 | 2.2 | 198 | 30,281 |
| 15:57:47 | 2.15 | 100 | 30,083 |
| 15:54:20 | 2.15 | 100 | 29,983 |
| 15:49:49 | 2.18 | 100 | 29,883 |
| 15:47:37 | 2.15 | 100 | 29,783 |
| 15:46:27 | 2.18 | 269 | 29,683 |
| 15:46:27 | 2.18 | 170 | 29,414 |
| 15:46:24 | 2.18 | 1,248 | 29,244 |
| 15:46:24 | 2.18 | 117 | 27,996 |
| 15:41:03 | 2.16 | 100 | 27,879 |
Monthly variations
Annual change
| 2024 | -43.34% | ||
| 2023 | -3.77% | ||
| 2022 | -7.90% | ||
| 2021 | -45.23% |
- Stock Market
- Equities
- ACXP Stock
- Quotes Acurx Pharmaceuticals, Inc.
